Skip to main content
HR 1184 117th Congress House

Helping Experts Accelerate Rare Treatments Act of 2021

Official title: To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.

Introduced: February 18, 2021 Introduced by: Tonko, Paul Democratic · New York See on congress.gov
Health Congressional oversightDrug safety, medical device, and laboratory regulationDrug therapyEuropean Union
More subjectsShow fewer subjects
Government information and archivesGovernment studies and investigationsHealth care coverage and accessHealth information and medical recordsLicensing and registrationsPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 19, 2021
Referred to the Subcommittee on Health.
Feb 18, 2021
Referred to the House Committee on Energy and Commerce.
Feb 18, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 19, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Helping Experts Accelerate Rare Treatments Act of 2021

This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.

The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 8
All 8 Democratic 1 Republican 3
D
Swalwell, Eric
California · Sep 28, 2022
 R
Bacon, Don
Nebraska · Feb 25, 2022
 R
Tenney, Claudia
New York · May 12, 2021
Murphy, Stephanie
· Apr 26, 2021
HASTINGS, ALCEE
· Mar 17, 2021
Jackson Lee, Sheila
· Mar 9, 2021
 R
Fitzpatrick, Brian K.
Pennsylvania · Feb 18, 2021
McKinley, David
· Feb 18, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1184: Helping Experts Accelerate Rare Treatments Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1184/
MLA
"H.R. 1184: Helping Experts Accelerate Rare Treatments Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1184/.
Bluebook (legal)
H.R. 1184, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1184/.
Markdown link
[H.R. 1184: Helping Experts Accelerate Rare Treatments Act of 2021](https://openamerica.io/bill/117-HR-1184/)
Report a problem